Selection of non-steroidal anti-inflammatory drug and treatment regimen for sulfur mustard-induced cutaneous lesions

References

• Papirmeister B, Feister AJ, Robinson SI, et al. Medical defense against mustard gas: toxic mechanisms and pharmacological implications. Boston, FL: CRC Press; 1991
   Google Scholar
• Graham JS, Chilcott RP, Rice P, et al. Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies. J Burns Wounds 2005;4:1–45
   PubMedGoogle Scholar
• Petrali JP, Oglesby SB, Hamilton TA, et al. Ultrastructural pathology and immunohistochemistry of mustard gas lesion. Proceedings of the 1993 medical defense bioscience review, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD. DTIC No. AD A275667; 1993:15–20
   Google Scholar
• Vogt RF, Dannenberg AM, Schofield BH, et al. Pathogenesis of skin lesions caused by sulfur mustard. Fund Appl Toxicol 1984;4:S71–S83
   PubMedGoogle Scholar
• Requena L, Requena C, Sanchez M, et al. Chemical warfare. Cutaneous lesions from mustard gas. J Am Acad Dermatol 1988;19:529–536
   PubMed Web of Science ®Google Scholar
• Sidell FR, Urbanetti JS, Smith WJ, et al. Vesicants. In: Sidell FR, Takafuji ET, Franz, DR, eds. Textbook of military medicine, part I: warfare, weaponry and the casualty – medical aspects of chemical and biological warfare. Washington, DC: Office of the Surgeon General at TMM Publications, Borden Institute, Walter Reed Army Medical Center; 1997:197–228
   Google Scholar
• Ghanei M, Aslani J, Khateri S, et al. Public health status of the civil population of Sardasht 15 years following large-scale wartime exposure to sulfur mustard. J Burns Surg Wound Care 2003;2:7
   Google Scholar
• Khateri S, Ghanei M, Soroush MR, et al. Effects of mustard gas exposure in pediatric patients: long-term health status of mustard-exposed children, 14 years after chemical bombardment of Sardasht. J Burns Surg Wound Care [serial online] 2003;2:12
   Google Scholar
• Marrs TC, Maynard RL, Sidell FR. Mustard gas. In: Anderson D, ed. Chemical warfare agents, toxicology and treatment, Chapter 6. West Sussex, England: John Wiley & Sons; 1996:139–173
   Google Scholar
• Mellor SG, Rice P, Cooper, GJ. Vesicant burns. Br J Plast Surg 1991;44:434–437
   PubMedGoogle Scholar
• Dillman JF III, McGary KL, Schlager JJ. An inhibitor of p38 MAP kinase downregulates cytokine release induced by sulfur mustard exposure in human epidermal keratinocytes. Toxicol In Vitro 2004;18:593–599
   PubMed Web of Science ®Google Scholar
• Mouret S, Wartelle J, Batal M, et al. Time course of skin features and inflammatory biomarkers after liquid sulfur mustard exposure in SKH-1 hairless mice. Toxicol Lett 2015;232:68–78
   PubMed Web of Science ®Google Scholar
• Dachir S, Fishbeine E, Sahar R, et al. Treating SM cutaneous injury with anti-inflammatory drugs – summing up and future prospects. Proceedings of the 2004 U.S. Army Medical Defense Bioscience Review, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD. 2004;140:1–21
   Google Scholar
• Willems JL. Clinical management of mustard gas casualties. Ann Med Milit Belg 1989;3S:31–61
   Google Scholar
• Smith WJ, Babin MC, Kiser RC, et al. Development of medical countermeasures to sulfur mustard vesication. In: Salem H, Katz SA, eds. Alternative toxicological methods. Boca Raton, FL: CRC Press; 2003:323–328
   Google Scholar
• Casillas RP, Kiser RC, Truxall JA, et al. Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J Appl Toxicol 2000;20:S145–S151
   PubMedGoogle Scholar
• Dachir S, Cohen M, Fishbeine E, et al. Characterization of acute and long-term sulfur mustard-induced skin injuries in hairless guinea-pigs using non-invasive methods. Skin Res Technol 2010;16:114–124
   PubMed Web of Science ®Google Scholar
• Cowan FM, Broomfield CA. Putative roles of inflammation in the dermatopathology of sulfur mustard. Cell Biol Toxicol 1993;9:201–213
   PubMed Web of Science ®Google Scholar
• Cowan FM, Broomfield CA, Smith WJ. Suppression of sulfur mustard-increased IL-8 in human keratinocyte cell cultures by serine protease inhibitors: implications for toxicity and medical countermeasures. Cell Biol Toxicol 2002;18:175–180
   PubMed Web of Science ®Google Scholar
• Swindle MM. Porcine models in surgical research: an overview. In: Tumbleson ME, ed. Swine in biomedical research. New York: Plenum Press; 1986:235–251
   Google Scholar
• Singer AJ, McClain SA. A porcine burn model. In: DiPietro LA, Burns AL, eds. Wound healing. Totowa, NJ: Humana Press; 2003:107–119
   Google Scholar
• EPA Research and Development-Interim Guidance for Dermal Exposure Assessment, Washington DC: US Environmental Protection Agency, EPA/600/8-91/011B. Jan 1992
   Google Scholar
• Mitcheltree LW, Mershon MM, Wall HG, et al. Microblister formation in vesicant-exposed pig skin. J Toxicol-Cut Ocular Toxicol 1989;8:309–319
   Web of Science ®Google Scholar
• Graham JS, Martin JL, Zallnick JE, et al. Assessment of cutaneous sulfur mustard injury in the weanling pig. Skin Res Technol 1999;5:56–67
   Google Scholar
• Graham JS, Reid FM, Smith JR, et al. A cutaneous full-thickness liquid sulfur mustard burn model in weanling swine: clinical pathology and urinary excretion of thiodiglycol. J Appl Toxicol 2000;20:S161–S172
   PubMedGoogle Scholar
• Rogers JV, Kohne JW, Graham JS, et al. Measuring liquid sulfur mustard recovery to characterize a weanling swine skin short-term exposure model. J Cut Ocular Toxicol 2005;24:177–185
   Google Scholar
• Reid FM, Niemuth NA, Shumaker SM, et al. Biomechanical monitoring of cutaneous sulfur mustard-induced lesions in the weanling pig model for depth of injury. Skin Res Technol 2007;13:217–225
   PubMed Web of Science ®Google Scholar
• Graham JS, Schomacker KT, Glatter RD, et al. Efficacy of laser debridement with autologous split-thickness skin grafting in promoting improved healing of deep cutaneous sulfur mustard burns. Burns 2002;28:719–730
   PubMed Web of Science ®Google Scholar
• Graham JS, Smith KG, Braue EH, et al. Improved healing of sulfur mustard-induced cutaneous lesions in the weanling pig by pulsed CO2 laser debridement. J Cut Ocular Toxicol 1997;16:275–295
   Web of Science ®Google Scholar
• Reid FM, Niemuth NA, Hayes TL, et al. Final report for task 94-33: in vivo evaluation of temporary wound dressings for adherence, durability and autografting on sulfur mustard-induced lesions in weanling swine; November 2000
   Google Scholar
• Reid FM, Vasconcelos D, Niemuth NA, et al. Final report for task order 12 of Contract DAMD17-99-D-0010: dose ranging and validation for superficial and superficial dermal, sulfur mustard-induced burns in the weanling swine model; November 2004
   Google Scholar
• Reid FM, Graham J, Niemuth NA, et al. Sulfur mustard-induced skin burns in weanling swine evaluated clinically and histopathologically. J Appl Toxicol 2000;20:S153–S160
   PubMedGoogle Scholar
• Hebda PA, Klingbeil CK, Abraham JA, et al. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol 1990;95:626–631
   PubMed Web of Science ®Google Scholar
• Dick IP, Scott RC. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol 1992;44:640–645
   PubMed Web of Science ®Google Scholar
• Paddock HN, Schultz GS, Mast BA. Methods in reepithelialization. In: DiPietro LA, Burns AL, eds. Wound healing. Totowa, NJ: Humana Press; 2003:17–36
   Google Scholar
• Chilcott RP, Jenner J, Hotchkiss SA, et al. In vitro skin absorption and decontamination of sulphur mustard: comparison of human and pig-ear skin. J Appl Toxicol 2001;21:279–283
   PubMed Web of Science ®Google Scholar
• Lindsay CD, Rice P. Changes in connective tissue macromolecular components of Yucatan mini-pig skin following application of sulphur mustard vapor. Hum Exp Toxicol 1995;14:341–348
   PubMed Web of Science ®Google Scholar
• Reid FM, Vasconcelos D, Niemuth NA, et al. Final report for task order 12 of Contract DAMD17-99-D-0010: dose ranging and validation for superficial and superficial dermal, sulfur mustard-induced burns in the weanling swine model; November 2004
   Google Scholar
• Graham JS, Reid FM, Smith JR, et al. A cutaneous full-thickness liquid sulfur mustard burn model in weanling swine: clinical pathology and urinary excretion of thiodiglycol. J Appl Toxicol 2000;20:S161–S172
   PubMedGoogle Scholar
• Reid FM, Kiser RC, Hart WE, et al. Steroid efficacy applied to two depths of dermal injuries induced by sulfur mustard or liquid bromine. Baltimore, MD: BioScience; 2008
   Google Scholar
• Babin MC, Ricketts K, Skvorak JP, et al. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J Appl Toxicol 2000;20(Suppl 1):S141–S144
   PubMedGoogle Scholar
• Young SC, Fabio KM, Huang M-T, et al. Investigation of anticholinergic and non-steroidal anti-inflammatory prodrugs which reduce chemically induced skin inflammation. J Appl Toxicol 2012;32:135–141
   PubMed Web of Science ®Google Scholar
• Dachir S, Fishbeine E, Meshulam Y, et al. Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID. J Appl Toxicol 2004;24:107–113
   PubMed Web of Science ®Google Scholar
• Sullivan JB, Stewart C, Phillips S. Weapons of mass destruction vesicants. In: Chase KH, ed. Clinical occupation environmental medicine. Philadelphia, PA: W.B. Saunders Company; 2003:279–290
   Google Scholar
• Ellison DH. Class Index C07, vesicants – sulfur based. In: Handbook of chemical and biological warfare agents. Boca Raton, FL: CRC Press LLC; 2000:259–264
   Google Scholar
• Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997;53:983–997
   PubMed Web of Science ®Google Scholar
• Wald A. Tests of statistical hypotheses concerning several parameters when the number of observations is large. Trans Ame Math Soc 1943;54:426–482
   Google Scholar
• Reid FM, Graham JS, Niemuth NA, et al. Comparison of two exposure times to produce superficial dermal sulfur mustard-induced lesion in the weanling swine model using histopathology. Presented at the 20th anniversary clinical symposium on advances in skin and wound care: the conference for prevention and healing; 2005, Las Vegas, NV
   Google Scholar
• Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin 2010;26:1715–1731
   PubMed Web of Science ®Google Scholar
• Geppetti P, Nassini R, Materazzi S, et al. The concept of neurogenic inflammation. BJU Int 2008;101:2–6
   PubMed Web of Science ®Google Scholar
• Zampetti A, Feliciani C, Tulli A, et al. Pharmacotherapy of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses focus on clobetasol propionate. Clin Med Insights: Ther 2010;2:523–537
   Google Scholar